Skip to main content
Image
CKM logo reversed
CKM
Cardiology Vascular Medical Education
Register for free Log in
Cardiovascular • Kidney • Metabolic
Lifelong learning for healthcare professionals
CVRM banner
CVRM banner

Home

About

About Us Advisory Board

Topics

View AllChronic Kidney DiseaseDiabetesCardiovascular Co-morbiditiesMetabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Obesity

Content type

Videos Articles Broadcasts Podcasts News

Faculty

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z View All

Events

Upcoming Events Radcliffe Events All Events

Resource Hubs

Inflammatory Risk in CVD Rise of CVRM
  • Content for healthcare professionals only
Image
CKM logo
Register for free Log in
Back to Main Menu

View all platforms

Cardiology Vascular CKM Medical Education
  • Content for healthcare professionals only

Breadcrumb

  • Home /
  • News Index

Latest News

BPROAD: Promising Results for Intensive Blood Pressure Control in Type 2 Diabetes Patients
Written by: Radcliffe CVRM
BPROAD: Promising Results for Intensive Blood Pressure Control in Type 2 Diabetes Patients
19 December 2024
AHA 24: PALISADE Trial Shows Promise for Patients with Familial Chylomicronemia Syndrome
Written by: Radcliffe Cardiology
AHA 24: PALISADE Trial Shows Promise for Patients with Familial Chylomicronemia Syndrome
19 December 2024
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
Written by: Radcliffe Cardiology
FLOW Trial Analysis: Deep Dive into the SGLT2-GLP-1 Combination Therapy
25 June 2024
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and Blood Pressure Control
Written by: Radcliffe Cardiology
Novel Agent Data for Obesity Released at ADA 2024 Scientific Sessions Show Benefits for Glycaemic and…
25 June 2024
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
Written by: Radcliffe Cardiology
SURMOUNT-OSA: Tirzepatide Significantly Improves Sleep Apnea and Cardiometabolic Risk Factors
24 June 2024
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
Written by: Radcliffe Cardiology
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors
31 May 2024
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular Disease
Written by: European Renal Association
Semaglutide May Protect Kidney Function in Individuals with Overweight or Obesity and Cardiovascular…
28 May 2024
Findings from an Apolipoprotein B-Based Genetic Analysis
Written by: Radcliffe Cardiology
New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL
06 February 2024

External news

Written by: Cardiovascular Business
Long-term cardiac amyloidosis survival benefits seen in extension acoramidis trial
07 April 2026
Written by: Cardiac Vascular News
Okami Medical Announces First Patient Enrolled in ALPHA Registry
07 April 2026
Written by: Cardiac Vascular News
InterVene Completes First 30 Cases Using the Recana® Thrombectomy Catheter System, Plans for Broader Commercial Launch
07 April 2026
Written by: Cardiovascular Business
Johnson & Johnson launches faster PFA system in Europe
07 April 2026
Written by: Cardiac Vascular News
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
07 April 2026
Written by: Cardiac Vascular News
HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification
07 April 2026
Written by: Cardiac Vascular News
Endospan Receives FDA Approval for the NEXUS® Aortic Arch Stent Graft System
07 April 2026
Written by: Cardiac Vascular News
Route 92 Medical Announces $50 Million Growth Financing
07 April 2026
Written by: Cardiovascular Business
FDA clears way for IDE pivotal trial of the Topaz tricuspid valve replacement system
07 April 2026
Written by: Cardiac Vascular News
Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers
07 April 2026
  • Load More

Footer Menu 1

  • About Us
  • Our team
  • Privacy
  • Terms & Conditions
  • Contact Us
  • Radcliffe Events
  • Radcliffe Group

Footer Menu 2

  • Authors A-Z
  • Image gallery
  • Industry Partners
  • Media Partners
  • Services
  • Promotional Opportunities

Quick Links 1

  • Heart Failure
  • Standards and Guidelines

Quick Links 2

  • Prevention and Chronic Conditions
  • Rise of CVRM
Register for FREE
CKM Logo

Copyright® 2026 Radcliffe Medical Media. All rights reserved.

Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media.

Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.